Clinical Trial Update: Comparison of Salivary Interleukin-1β and Matrix Metalloproteinase-8 Levels in Individuals With Chronic Periodontitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update investigating salivary biomarkers interleukin-1β and matrix metalloproteinase-8 in individuals with chronic periodontitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontitis

Snippet

Sponsor: University of Health Sciences Lahore | Conditions: Chronic Periodontitis | Phase 2 | Status: UNKNOWN